Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Depreciation & Amortization (CF) (2019 - 2025)

Outset Medical (OM) has disclosed Depreciation & Amortization (CF) for 7 consecutive years, with $881000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 37.34% to $881000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 24.21% decrease, with the full-year FY2025 number at $4.3 million, down 24.21% from a year prior.
  • Depreciation & Amortization (CF) was $881000.0 for Q4 2025 at Outset Medical, down from $1.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q2 2023 to a low of $881000.0 in Q4 2025.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): soared 308.52% in 2021, then tumbled 37.34% in 2025.
  • Outset Medical's Depreciation & Amortization (CF) stood at $1.3 million in 2021, then fell by 2.08% to $1.3 million in 2022, then grew by 13.95% to $1.4 million in 2023, then fell by 2.77% to $1.4 million in 2024, then crashed by 37.34% to $881000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Depreciation & Amortization (CF) are $881000.0 (Q4 2025), $1.0 million (Q3 2025), and $1.2 million (Q2 2025).